About

Company description

We are CuraLife, an international consumer healthcare company founded in 2013.
We are an innovative company with one main focus: Improving the metabolic well-being of people worldwide, through nutraceuticals solutions now used for years by hundreds of thousands of consumers, supported by high-quality clinical studies. 
We develop smart devices and AI applications to simplify personal health journeys to live life at fullest. Our technologies are driven from our consumer intelligence, creating points of interaction with our users.  We create personalized health journeys
for each and every individual.

Our key product, curalin, is a premium Herbal Dietary Supplement with proven efficacy in promoting a healthy glycemic response, energy levels and metabolism of carbs and fats. CuraLin has a unique formula, composed by 9 natural ingredients which is the result of more than 4 years of R&D. 
According to published randomized, double-blind, placebo-controlled clinical evidence CuraLin is a safe and effective add-on therapy to first-line o...

Quick facts

Sales markets Africa; Asia; Eastern Europe; Middle East; North America; Western Europe
Primary business activity Manufacturer: Finished Food Products
Affiliated categories: Botanical Extracts More

Recently at

1 may 2023

Vitafoods Europe Online and In-Person

1 - 12 May 2023 - Online We were at stand L295, N303 See our Exhibitor Profile   See full Exhibitor List

News about CuraLife Ltd

Curalin Randomized, Double-blind, Placebo-controlled clinical trial reaches UK media

20 Mar 2023

Curalin Randomized, Double-blind, Placebo-controlled clinical trial reaches UK media

A news-piece, published in The Express mentions the good results of curalin's first published RDBPC clinical trial.

Read more

17 Mar 2023

Curalin Randomized, Double-blind, Placebo Controlled Clinical Trial published in Diabetes Metabolism Research and Reviews

According to a Double-blind, Placebo Controlled Clinical Trial published in Diabetes Metabolism Research and Reviews, curalin is well-tolerated and significantly reduces HbA1c.

Read more

17 Mar 2023

The study of curalin as add-on therapy in adults with type 2 diabetes mellitus

Published news announcing Curalife starting the clinical study testing curalin as add-on therapy in adults with type 2 diabetes mellitus

Read more

15 Mar 2023

Curalife signs exclusive distribution agreement for Malaysia and Singapore

Curalife signs exclusive distribution agreement for Malaysia and Singapore with LYC Healthcare. Find out more.

Read more

Categories affiliated with CuraLife Ltd

CuraLife Ltd

Contact information

Address

Telephone

Website

View all contact information